Published: May 18, 2021, 07:02 IST | Updated: May 18, 2021, 07:02 IST
The national drug regulator, Drugs Controller General of India (DCGI), had cleared the formulation on May 1 for emergency use as an adjunct therapy in moderate to severe Covid-19 patients.